Automated Author ProfileSchneider, M.
Schneider, M.
Current S-Index
Sum of Dataset Indices for all datasets
Average Dataset Index per Dataset
Average Dataset Index per dataset
Total Datasets
Total datasets for this author
Average FAIR Score
Average FAIR Score per dataset
Total Citations
Total citations to the author's datasets
Total Mentions
Total mentions of the author's datasets
S-Index Interpretation
The S-Index (Sharing Index) is a comprehensive metric that represents the cumulative impact of all your datasets. It is calculated as the sum of Dataset Index scores across all your claimed datasets.
What it means:
- A higher S-index indicates greater overall impact of your datasets relative to typical datasets in their fields of research
- The S-Index grows as you add more datasets or as existing datasets gain more citations and mentions
- It provides a single number to track your research data impact over time
Current S-Index: 10.2 (sum of 19 datasets Dataset Index scores)
More information here.
S-Index Over Time
Cumulative Citations Over Time
Cumulative Mentions Over Time
Datasets
No description available
Authors
- Albert, A. ;
- Alfaro, R. ;
- Alvarez, C. ;
- Camacho J.R.A. ;
- Arteaga-Velazquez, J.C. ;
- Arunbabu, K.P. ;
- Rojas, D.A. ;
- Ayala Solares, H.A. ;
- Baghmanyan, V. ;
- Belmont-Moreno, E. ;
- BenZvi, S.Y. ;
- Brisbois, C. ;
- Capistran, T. ;
- Carraminana, A. ;
- Casanova, S. ;
- Cotti, U. ;
- Cotzomi, J. ;
- De La Fuente, E. ;
- Hernandez, R.D. ;
- Dingus, B.L. ;
- DuVernois, M.A. ;
- Durocher, M. ;
- Diaz-Velez, J.C. ;
- Engel, K. ;
- Espinoza, C. ;
- Fang, K. ;
- Fleischhack, H. ;
- Fraija, N. ;
- Galvan-Gamez, A. ;
- Garcia, D. ;
- Garcia-Gonzalez, J.A. ;
- Garfias, F. ;
- Giacinti, G. ;
- Gonzalez, M.M. ;
- Goodman, J.A. ;
- Harding, J.P. ;
- Hona, B. ;
- Huang, D. ;
- Hueyotl-Zahuantitla, F. ;
- Huntemeyer, P. ;
- Iriarte, A. ;
- Jardin-Blicq, A. ;
- Joshi, V. ;
- Kunde, G.J. ;
- Lara, A. ;
- Lee, W.H. ;
- Vargas, H.L. ;
- Linnemann, J.T. ;
- Longinotti, A.L. ;
- Luis-Raya, G. ;
- Lundeen, J. ;
- Malone, K. ;
- Marandon, V. ;
- Martinez, O. ;
- Martinez-Castro, J. ;
- Matthews, J.A. ;
- Miranda-Romagnoli, P. ;
- Moreno, E. ;
- Mostafa, M. ;
- Nayerhoda, A. ;
- Nellen, L. ;
- Newbold, M. ;
- Nisa, M.U. ;
- Noriega-Papaqui, R. ;
- Omodei, N. ;
- Peisker, A. ;
- Araujo, Y.P. ;
- Perez-Perez, E.G. ;
- Rho, C.D. ;
- Rosa-Gonzalez, D. ;
- Salazar, H. ;
- Greus, F.S. ;
- Sandoval, A. ;
- Schneider, M. ;
- Serna, F. ;
- Springer, R.W. ;
- Tollefson, K. ;
- Torres, I. ;
- Torres-Escobedo, R. ;
- Urena-Mena, F. ;
- Villasenor, L. ;
- Willox, E. ;
- Zhou, H. ;
- De Leon, C.
No description available
Authors
- Albert, A. ;
- Alvarez, C. ;
- Camacho J.R.A. ;
- Arteaga-Velazquez, J.C. ;
- Arunbabu, K.P. ;
- Rojas, D.A. ;
- Solares H.A.A. ;
- Baghmanyan, V. ;
- Belmont-Moreno, E. ;
- BenZvi, S.Y. ;
- Brisbois, C. ;
- Caballero-Mora, K.S. ;
- Capistran, T. ;
- Carraminana, A. ;
- Casanova, S. ;
- Cotti, U. ;
- Cotzomi, J. ;
- De Leon, S.C. ;
- De La Fuente, E. ;
- Dingus, B.L. ;
- DuVernois, M.A. ;
- Durocher, M. ;
- Diaz-Velez, J.C. ;
- Engel, K. ;
- Espinoza, C. ;
- Fan, K.L. ;
- Alonso, M.F. ;
- Fleischhack, H. ;
- Fraija, N. ;
- Galvan-Gamez, A. ;
- Garcia, D. ;
- Garcia-Gonzalez, J.A. ;
- Garfias, F. ;
- Gonzalez, M.M. ;
- Goodman, J.A. ;
- Harding, J.P. ;
- Hernandez, S. ;
- Hona, B. ;
- Huang, D. ;
- Hueyotl-Zahuantitla, F. ;
- Huntemeyer, P. ;
- Iriarte, A. ;
- Jardin-Blicq, A. ;
- Joshi, V. ;
- Kieda, D. ;
- Kunde, G.J. ;
- Lara, A. ;
- Lee, W.H. ;
- Vargas, H.L. ;
- Linnemann, J.T. ;
- Longinotti, A.L. ;
- Luis-Raya, G. ;
- Lundeen, J. ;
- Malone, K. ;
- Martinez, O. ;
- Martinez-Castellanos, I. ;
- Martinez-Castro, J. ;
- Matthews, J.A. ;
- Miranda-Romagnoli, P. ;
- Morales-Soto, J.A. ;
- Moreno, E. ;
- Mostafa, M. ;
- Nayerhoda, A. ;
- Nellen, L. ;
- Newbold, M. ;
- Nisa, M.U. ;
- Noriega-Papaqui, R. ;
- Olivera-Nieto, L. ;
- Peisker, A. ;
- Perez-Perez, E.G. ;
- Rho, C.D. ;
- Rosa-Gonzalez, D. ;
- Ruiz-Velasco, E. ;
- Salazar, H. ;
- Greus, F.S. ;
- Sandoval, A. ;
- Schneider, M. ;
- Schoorlemmer, H. ;
- Smith, A.J. ;
- Springer, R.W. ;
- Tollefson, K. ;
- Torres, I. ;
- Torres-Escobedo, R. ;
- Urena-Mena, F. ;
- Villasenor, L. ;
- Weisgarber, T. ;
- Willox, E. ;
- Zepeda, A. ;
- Zhou, H. ;
- De Leon, C. ;
- Collaboration, The HAWC
No description available
Authors
- Albert, A. ;
- Alfaro, R. ;
- Alvarez, C. ;
- Angeles Camacho, J.R. ;
- Arteaga-Velazquez, J.C. ;
- Arunbabu, K.P. ;
- Avila Rojas, D. ;
- Ayala Solares, H.A. ;
- Baghmanyan, V. ;
- Belmont-Moreno, E. ;
- BenZvi, S.Y. ;
- Brisbois, C. ;
- Caballero-Mora, K.S. ;
- Capistran, T. ;
- Carraminana, A. ;
- Casanova, S. ;
- Cotti, U. ;
- Coutino De Leon, S. ;
- De La Fuente, E. ;
- Diaz Hernandez, R. ;
- Diaz-Cruz, L. ;
- Dingus, B.L. ;
- DuVernois, M.A. ;
- Durocher, M. ;
- Diaz-Velez, J.C. ;
- Ellsworth, R.W. ;
- Engel, K. ;
- Espinoza, C. ;
- Fan, K.L. ;
- Fang, K. ;
- Fernandez Alonso, M. ;
- Fleischhack, H. ;
- Fraija, N. ;
- Galvan-Gamez, A. ;
- Garcia, D. ;
- Garcia-Gonzalez, J.A. ;
- Garfias, F. ;
- Giacinti, G. ;
- Gonzalez, M.M. ;
- Goodman, J.A. ;
- Harding, J.P. ;
- Hernandez, S. ;
- Hinton, J. ;
- Hona, B. ;
- Huang, D. ;
- Hueyotl-Zahuantitla, F. ;
- Huntemeyer, P. ;
- Iriarte, A. ;
- Jardin-Blicq, A. ;
- Joshi, V. ;
- Kieda, D. ;
- Lara, A. ;
- Lee, W.H. ;
- Leon Vargas, H. ;
- Linnemann, J.T. ;
- Longinotti, A.L. ;
- Luis-Raya, G. ;
- Lundeen, J. ;
- Lopez-Coto, R. ;
- Malone, K. ;
- Marandon, V. ;
- Martinez, O. ;
- Martinez-Castellanos, I. ;
- Martinez-Castro, J. ;
- Matthews, J.A. ;
- Miranda-Romagnoli, P. ;
- Morales-Soto, J.A. ;
- Moreno, E. ;
- Mostafa, M. ;
- Nayerhoda, A. ;
- Nellen, L. ;
- Newbold, M. ;
- Nisa, M.U. ;
- Noriega-Papaqui, R. ;
- Olivera-Nieto, L. ;
- Omodei, N. ;
- Peisker, A. ;
- Perez Araujo, Y. ;
- Perez-Perez, E.G. ;
- Ren, Z. ;
- Rho, C.D. ;
- Riviere, C. ;
- Rosa-Gonzalez, D. ;
- Ruiz-Velasco, E. ;
- Salazar, H. ;
- Salesa Greus, F.S. ;
- Sandoval, A. ;
- Schneider, M. ;
- Schoorlemmer, H. ;
- Serna, F. ;
- Sinnis, G. ;
- Smith, A.J. ;
- Springer, R.W. ;
- Surajbali, P. ;
- Tollefson, K. ;
- Torres, I. ;
- Torres-Escobedo, R. ;
- Ukwatta, T.N. ;
- Urena-Mena, F. ;
- Weisgarber, T. ;
- Werner, F. ;
- Willox, E. ;
- Zepeda, A. ;
- Zhou, H. ;
- De Leon, C. ;
- Alvarez, J.D. ;
- Collaboration, The HAWC
No description available
Authors
- Abeysekara, A.U. ;
- Albert, A. ;
- Alfaro, R. ;
- Alvarez, C. ;
- Alvarez, J.D. ;
- Arceo, R. ;
- Arteaga-Velazquez, J.C. ;
- Ayala Solares, H.A. ;
- Barber, A.S. ;
- Baughman, B. ;
- Bautista-Elivar, N. ;
- Becerra Gonzalez, J. ;
- Becerril, A. ;
- Belmont-Moreno, E. ;
- Benzvi, S.Y. ;
- Berley, D. ;
- Bernal, A. ;
- Braun, J. ;
- Brisbois, C. ;
- Caballero-Mora, K.S. ;
- Capistran, T. ;
- Carraminana, A. ;
- Casanova, S. ;
- Castillo, M. ;
- Cotti, U. ;
- Cotzomi, J. ;
- Coutino De Leon, S. ;
- De La Fuente, E. ;
- De Leon, C. ;
- Diaz Hernandez, R. ;
- Dingus, B.L. ;
- Duvernois, M.A. ;
- Diaz-Velez, J.C. ;
- Ellsworth, R.W. ;
- Engel, K. ;
- Fiorino, D.W. ;
- Fraija, N. ;
- Garcia-Gonzalez, J.A. ;
- Garfias, F. ;
- Gerhardt, M. ;
- Gonzalez Munoz, A. ;
- Gonzalez, M.M. ;
- Goodman, J.A. ;
- Hampel-Arias, Z. ;
- Harding, J.P. ;
- Hernandez, S. ;
- Hernandez-Almada, A. ;
- Hinton, J. ;
- Hui, C.M. ;
- Huntemeyer, P. ;
- Iriarte, A. ;
- Jardin-Blicq, A. ;
- Joshi, V. ;
- Kaufmann, S. ;
- Kieda, D. ;
- Lara, A. ;
- Lauer, R.J. ;
- Lee, W.H. ;
- Lennarz, D. ;
- Leon Vargas, H. ;
- Linnemann, J.T. ;
- Longinotti, A.L. ;
- Luis Raya, G. ;
- Luna-Garcia, R. ;
- Lopez-Coto, R. ;
- Malone, K. ;
- Marinelli, S.S. ;
- Martinez, O. ;
- Martinez-Castellanos, I. ;
- Martinez-Castro, J. ;
- Martinez-Huerta, H. ;
- Matthews, J.A. ;
- Miranda-Romagnoli, P. ;
- Moreno, E. ;
- Mostafa, M. ;
- Nellen, L. ;
- Newbold, M. ;
- Nisa, M.U. ;
- Noriega-Papaqui, R. ;
- Pelayo, R. ;
- Pretz, J. ;
- Perez-Perez, E.G. ;
- Ren, Z. ;
- Rho, C.D. ;
- Riviere, C. ;
- Rosa-Gonzalez, D. ;
- Rosenberg, M. ;
- Ruiz-Velasco, E. ;
- Salazar, H. ;
- Salesa Greus, F. ;
- Sandoval, A. ;
- Schneider, M. ;
- Schoorlemmer, H. ;
- Sinnis, G. ;
- Smith, A.J. ;
- Springer, R.W. ;
- Surajbali, P. ;
- Taboada, I. ;
- Tibolla, O. ;
- Tollefson, K. ;
- Torres, I. ;
- Ukwatta, T.N. ;
- Vianello, G. ;
- Villasenor, L. ;
- Weisgarber, T. ;
- Westerhoff, S. ;
- Wisher, I.G. ;
- Wood, J. ;
- Yapici, T. ;
- Younk, P.W. ;
- Zepeda, A. ;
- Zhou, H.
The specific contents of human consciousness rely on the activity of specialized neurons in cerebral cortex. We hypothesized that the conscious experience of a specific visual motion axis is reflected in response amplitudes of direction-selective clusters in the human motion complex. Using submillimeter fMRI at ultrahigh field (7 T) we identified fine-grained clusters that were tuned to either horizontal or vertical motion presented in an unambiguous motion display. We then recorded their responses while human observers reported the perceived axis of motion for an ambiguous apparent motion display. Although retinal stimulation remained constant, subjects reported recurring changes between horizontal and vertical motion percepts every 7 to 13 s. We found that these perceptual states were dissociatively reflected in the response amplitudes of the identified horizontal and vertical clusters. We also found that responses to unambiguous motion were organized in a columnar fashion such that motion preferences were stable in the direction of cortical depth and changed when moving along the cortical surface. We suggest that activity in these specialized clusters is involved in tracking the distinct conscious experience of a particular motion axis.
Authors
- Schneider, M. ;
- Kemper, V. G. ;
- Emmerling, T. C. ;
- De Martino, F. ;
- Goebel, R.
Background: There are limited data on outcomes of patients undergoing peripheral arterial disease (PAD) interventions who have comorbid CKD/ESRD versus those who do not have such comorbid condition. We performed a systematic review and meta-analysis to analyze outcomes in this patient population. Methods: Five databases were searched for studies comparing outcomes of lower extremity PAD interventions for claudication and critical limb ischemia (CLI) in patients with CKD/ESRD versus non-CKD/non-ESRD from January 2000 to June 2019. Results: Our study included 16 observational studies with 44,138 patients. Mean follow-up was 48.9 ± 27.4 months. Major amputation was higher with CKD/ESRD compared with non-CKD/non-ESRD (odds ratio [OR 1.97] [95% confidence interval [CI] 1.39–2.80], p = 0.001). Higher major amputations with CKD/ESRD versus non-CKD/non-ESRD were only observed when indication for procedure was CLI (OR 2.27 [95% CI 1.53–3.36], p < 0.0001) but were similar for claudication (OR 1.15 [95% CI 0.53–2.49], p = 0.72). The risk of early mortality was high with CKD/ESRD patients undergoing PAD interventions compared with non-CKD/non-ESRD (OR 2.55 [95% CI 1.65–3.96], p < 0.0001), which when stratified based on indication, remained higher with CLI (OR 3.14 [95% CI 1.80–5.48], p < 0.0001) but was similar with claudication (OR 1.83 [95% CI 0.90–3.72], p = 0.1). Funnel plot of included studies showed moderate bias. Conclusions: Patients undergoing lower extremity PAD interventions for CLI who also have comorbid CKD/ESRD have an increased risk of experiencing major amputations and early mortality. Randomized trials to understand outcomes of PAD interventions in this at-risk population are essential.
Authors
- Anantha-Narayanan, M. ;
- Sheikh, A.B. ;
- Nagpal, S. ;
- Smolderen, K.G. ;
- Turner, J. ;
- Schneider, M. ;
- Llanos-Chea, F. ;
- Mena-Hurtado, C.
Background: Primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoproliferative disorder (SMPLPD) is a provisional entity within the 2016 World Health Organization classification of primary cutaneous lymphomas. The condition is currently classified as a lymphoproliferative disorder to emphasize its benign course and discourage aggressive, systemic treatment modalities. Objective: To provide a relevant synthesis for the dermatological practitioner on the prevalence, presentation, and treatment of SMPLPD. Methods: We conducted an updated systematic literature review and a retrospective chart review of diagnosed cases of SMPLPD from 2 Canadian academic cutaneous lymphoma centers. Results: A total of 23 studies with 136 cases were extracted from the systematic review and 24 patients from our retrospective chart review. SMPLPD proved relatively common accounting for 12.5% of all cutaneous T-cell lymphomas encountered in our cutaneous lymphoma clinics, second in frequency only to mycosis fungoides. The typical clinical presentation was that of an older individual (median age 59 years) with an asymptomatic solitary lesion on their upper extremity. The most common clinical differentials were cutaneous lymphoid hyperplasia, basal cell carcinoma, and lymphoma unspecified. T follicular helper markers were reliably detected. The main treatment modalities were surgical excision, local radiation therapy, and topical or intralesional steroids. Cure was achieved in the vast majority of cases. Conclusions: SMPLPD is an underdiagnosed T-cell lymphoma with an overtly benign clinical course. The condition has an excellent prognosis and responds well to skin-directed therapies. Practitioners should be aware of this condition to avoid aggressive systemic treatments.
Authors
- Surmanowicz, P. ;
- Doherty, S. ;
- Sivanand, A. ;
- Parvinnejad, N. ;
- Deschenes, J. ;
- Schneider, M. ;
- Hardin, J. ;
- Gniadecki, R.
Background: There are limited data on outcomes of patients undergoing peripheral arterial disease (PAD) interventions who have comorbid CKD/ESRD versus those who do not have such comorbid condition. We performed a systematic review and meta-analysis to analyze outcomes in this patient population. Methods: Five databases were searched for studies comparing outcomes of lower extremity PAD interventions for claudication and critical limb ischemia (CLI) in patients with CKD/ESRD versus non-CKD/non-ESRD from January 2000 to June 2019. Results: Our study included 16 observational studies with 44,138 patients. Mean follow-up was 48.9 ± 27.4 months. Major amputation was higher with CKD/ESRD compared with non-CKD/non-ESRD (odds ratio [OR 1.97] [95% confidence interval [CI] 1.39–2.80], p = 0.001). Higher major amputations with CKD/ESRD versus non-CKD/non-ESRD were only observed when indication for procedure was CLI (OR 2.27 [95% CI 1.53–3.36], p < 0.0001) but were similar for claudication (OR 1.15 [95% CI 0.53–2.49], p = 0.72). The risk of early mortality was high with CKD/ESRD patients undergoing PAD interventions compared with non-CKD/non-ESRD (OR 2.55 [95% CI 1.65–3.96], p < 0.0001), which when stratified based on indication, remained higher with CLI (OR 3.14 [95% CI 1.80–5.48], p < 0.0001) but was similar with claudication (OR 1.83 [95% CI 0.90–3.72], p = 0.1). Funnel plot of included studies showed moderate bias. Conclusions: Patients undergoing lower extremity PAD interventions for CLI who also have comorbid CKD/ESRD have an increased risk of experiencing major amputations and early mortality. Randomized trials to understand outcomes of PAD interventions in this at-risk population are essential.
Authors
- Anantha-Narayanan, M. ;
- Sheikh, A.B. ;
- Nagpal, S. ;
- Smolderen, K.G. ;
- Turner, J. ;
- Schneider, M. ;
- Llanos-Chea, F. ;
- Mena-Hurtado, C.
Background: Primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoproliferative disorder (SMPLPD) is a provisional entity within the 2016 World Health Organization classification of primary cutaneous lymphomas. The condition is currently classified as a lymphoproliferative disorder to emphasize its benign course and discourage aggressive, systemic treatment modalities. Objective: To provide a relevant synthesis for the dermatological practitioner on the prevalence, presentation, and treatment of SMPLPD. Methods: We conducted an updated systematic literature review and a retrospective chart review of diagnosed cases of SMPLPD from 2 Canadian academic cutaneous lymphoma centers. Results: A total of 23 studies with 136 cases were extracted from the systematic review and 24 patients from our retrospective chart review. SMPLPD proved relatively common accounting for 12.5% of all cutaneous T-cell lymphomas encountered in our cutaneous lymphoma clinics, second in frequency only to mycosis fungoides. The typical clinical presentation was that of an older individual (median age 59 years) with an asymptomatic solitary lesion on their upper extremity. The most common clinical differentials were cutaneous lymphoid hyperplasia, basal cell carcinoma, and lymphoma unspecified. T follicular helper markers were reliably detected. The main treatment modalities were surgical excision, local radiation therapy, and topical or intralesional steroids. Cure was achieved in the vast majority of cases. Conclusions: SMPLPD is an underdiagnosed T-cell lymphoma with an overtly benign clinical course. The condition has an excellent prognosis and responds well to skin-directed therapies. Practitioners should be aware of this condition to avoid aggressive systemic treatments.
Authors
- Surmanowicz, P. ;
- Doherty, S. ;
- Sivanand, A. ;
- Parvinnejad, N. ;
- Deschenes, J. ;
- Schneider, M. ;
- Hardin, J. ;
- Gniadecki, R.
The ILK Dresden designs, develops and manufactures customized non-metallic cryostats for very different applications. For the needs of a wide variety of applications both, geometrical constraints and material selection, can be realized. These cryostats are characterized by long holding time of vacuum and hence they exhibit a very long storage time of the cryogenic fluid. Not only the cryostat itself is of crucial importance to the functionality, but also the fixtures needed as a carrier for measurements inside a cryostat. Minimized thermal expansion, low vibration, maximum variability and low magnetic noise are possible features of thecryostats. Various material-testing and experimental results are presented as well as special solutions for applications and details of construction. The following points are also discussed: Properties of a cryostat for elevated ambient temperatures of the cryostats, Geometrical limitations, Important aspects in the design of low-noise magnetic-field cryostats. Cryostats for LN2 and LHe can also be designed, manufactured, and approved for pressure applications according to the European Pressure Vessel Regulation (Pressure Equipment Directive (PED) 2014/68/EU).
Authors
- TROMMLER, G. ;
- BOEHM, U. ;
- SCHNEIDER, M. ;
- Et Al.